What warrants a call to your provider Nausea or vomiting that prevents you from eating or drinking for more than 24 hours Significant dehydration symptoms: dark urine, dizziness, rapid heartbeat Abdominal pain that is sharp, severe, or worsening Side effects that do not improve at all after 34 weeks on the same dose Any new symptom that feels different from your typical GI adjustment pattern Serious warning signs Serious adverse events on GLP-1 medications are rare, but they do exist
Some patients arrange to overlap the last week of liraglutide with the PA approval window for the new drug to avoid treatment gaps
Apply evenly to affected areas of scalp once daily
Before switching because of GI intolerance, we recommend ensuring that all reasonable mitigating actions have been implemented, including: 1 ) verifying that the patient is taking the prescribed dose of the current GLP-1 receptor agonist because dose reduction can often minimize or resolve GI symptoms
Retatrutide fatigue refers to the sensation of tiredness or decreased energy that some users encounter when using retatrutide, an experimental drug for weight control
